Access

Letter

Nature 445, 931-935 (22 February 2007) | doi:10.1038/nature05478; Received 13 October 2006; Accepted 27 November 2006; Published online 21 January 2007

Open Innovation Challenges

naturejobs

  • Chair

    • McMaster University
    • Hamilton, Canada
  • PhD student position

    • Laval University Cancer Research Center
    • Quebec city, CANADA

Foxp3 occupancy and regulation of key target genes during T-cell stimulation

Alexander Marson1,2,8, Karsten Kretschmer6,7,8, Garrett M. Frampton1,2, Elizabeth S. Jacobsen1, Julia K. Polansky6, Kenzie D. MacIsaac3, Stuart S. Levine1, Ernest Fraenkel4,5, Harald von Boehmer6,7 & Richard A. Young1,2

  1. Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA
  2. Department of Biology,
  3. Department of Electrical Engineering and Computer Science,
  4. Biological Engineering Division,
  5. Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
  6. Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA
  7. Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA
  8. These authors contributed equally to this work

Correspondence to: Harald von Boehmer6,7Richard A. Young1,2 Correspondence and requests for materials should be addressed to R.A.Y. (Email: young@wi.mit.edu) or H.v.B. (Email: Harald_von_Boehmer@dfci.harvard.edu).

Top

Foxp3+CD4+CD25+ regulatory T (Treg) cells are essential for the prevention of autoimmunity1, 2. Treg cells have an attenuated cytokine response to T-cell receptor stimulation, and can suppress the proliferation and effector function of neighbouring T cells3, 4. The forkhead transcription factor Foxp3 (forkhead box P3) is selectively expressed in Treg cells, is required for Treg development and function, and is sufficient to induce a Treg phenotype in conventional CD4+CD25- T cells5, 6, 7, 8. Mutations in Foxp3 cause severe, multi-organ autoimmunity in both human and mouse9, 10, 11. FOXP3 can cooperate in a DNA-binding complex with NFAT (nuclear factor of activated T cells) to regulate the transcription of several known target genes12. However, the global set of genes regulated directly by Foxp3 is not known and consequently, how this transcription factor controls the gene expression programme for Treg function is not understood. Here we identify Foxp3 target genes and report that many of these are key modulators of T-cell activation and function. Remarkably, the predominant, although not exclusive, effect of Foxp3 occupancy is to suppress the activation of target genes on T-cell stimulation. Foxp3 suppression of its targets appears to be crucial for the normal function of Treg cells, because overactive variants of some target genes are known to be associated with autoimmune disease.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Regulatory T-cell development: is Foxp3 the decider?

Nature Medicine News and Views (01 Mar 2007)

Regulatory T-cell development: is Foxp3 the decider?

Nature Medicine News and Views (01 Mar 2007)

See all 3 matches for News And Views